Sanofi SA (PA:SAN) — Market Cap & Net Worth
Market Cap & Net Worth: Sanofi SA (SAN)
Sanofi SA (PA:SAN) has a market capitalization of $95.70 Billion (€81.86 Billion) as of June 4, 2026. Listed on the PA stock exchange, this France-based company holds position #266 globally and #10 in its home market, demonstrating a -3.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sanofi SA's stock price €73.52 by its total outstanding shares 1207641512 (1.21 Billion). Review SAN liabilities breakdown to assess the company's total debt and financial obligations.
Sanofi SA Market Cap History: 2015 to 2026
Sanofi SA's market capitalization history from 2015 to 2026. Data shows growth from $77.90 Billion to $103.80 Billion (1.53% CAGR).
Index Memberships
Sanofi SA is a constituent of 7 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
CAC Large 60
CACLG
|
$2.61 Trillion | 3.66% | #10 of 60 |
|
CAC All-Tradable
CACT
|
$2.85 Trillion | 3.36% | #10 of 179 |
|
CAC All-Tradable Net Total Return
CACTN
|
$2.85 Trillion | 3.36% | #10 of 179 |
|
CAC All Tradable Gross Total Return
CACTR
|
$2.85 Trillion | 3.36% | #10 of 179 |
|
CAC 40
FCHI
|
$2.48 Trillion | 3.86% | #10 of 40 |
|
CAC Health Care
FRHC
|
$252.21 Billion | 37.94% | #1 of 36 |
|
EuroNext 100
N100
|
$3.48 Trillion | 2.75% | #10 of 97 |
Weight: Sanofi SA's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Sanofi SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sanofi SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.68x
Sanofi SA's market cap is 2.68 times its annual revenue
Latest Price to Earnings (P/E) Ratio
14.95x
Sanofi SA's market cap is 14.95 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $79.47 Billion | $34.70 Billion | $4.71 Billion | 2.29x | 16.88x |
| 2017 | $76.71 Billion | $36.22 Billion | $8.42 Billion | 2.12x | 9.11x |
| 2018 | $84.68 Billion | $35.68 Billion | $4.31 Billion | 2.37x | 19.66x |
| 2019 | $104.53 Billion | $37.63 Billion | $2.75 Billion | 2.78x | 37.95x |
| 2020 | $95.20 Billion | $37.37 Billion | $12.29 Billion | 2.55x | 7.74x |
| 2021 | $111.27 Billion | $39.17 Billion | $6.22 Billion | 2.84x | 17.88x |
| 2022 | $117.40 Billion | $40.30 Billion | $8.37 Billion | 2.91x | 14.03x |
| 2023 | $121.68 Billion | $41.11 Billion | $5.40 Billion | 2.96x | 22.53x |
| 2024 | $132.35 Billion | $44.29 Billion | $5.56 Billion | 2.99x | 23.80x |
| 2025 | $116.79 Billion | $43.63 Billion | $7.81 Billion | 2.68x | 14.95x |
Competitor Companies of SAN by Market Capitalization
Companies near Sanofi SA in the global market cap rankings as of June 4, 2026.
Key companies related to Sanofi SA by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #14 globally with a market cap of $936.50 Billion USD.
- Eli Lilly and Company (SA:LILY34): Ranked #17 globally with a market cap of $853.51 Billion USD ( R$4.35 Trillion BRL).
- Johnson & Johnson (NYSE:JNJ): Ranked #28 globally with a market cap of $537.85 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #40 globally with a market cap of $356.49 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #14 | Eli Lilly and Company | NYSE:LLY | $936.50 Billion | $1078.78 |
| #17 | Eli Lilly and Company | SA:LILY34 | $853.51 Billion | R$153.70 |
| #28 | Johnson & Johnson | NYSE:JNJ | $537.85 Billion | $223.24 |
| #40 | AbbVie Inc | NYSE:ABBV | $356.49 Billion | $217.13 |
Sanofi SA Historical Marketcap From 2015 to 2026
Between 2015 and today, Sanofi SA's market cap moved from $77.90 Billion to $ 103.80 Billion, with a yearly change of 1.53%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €103.80 Billion | -11.12% |
| 2025 | €116.79 Billion | -11.76% |
| 2024 | €132.35 Billion | +8.77% |
| 2023 | €121.68 Billion | +3.64% |
| 2022 | €117.40 Billion | +5.51% |
| 2021 | €111.27 Billion | +16.88% |
| 2020 | €95.20 Billion | -8.92% |
| 2019 | €104.53 Billion | +23.44% |
| 2018 | €84.68 Billion | +10.39% |
| 2017 | €76.71 Billion | -3.48% |
| 2016 | €79.47 Billion | +2.02% |
| 2015 | €77.90 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 4th, 2026 the market cap of Sanofi SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $95.70 Billion USD |
| MoneyControl | $95.70 Billion USD |
| MarketWatch | $95.70 Billion USD |
| marketcap.company | $95.70 Billion USD |
| Reuters | $95.70 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sanofi SA
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting aga… Read more